BRPI0509881A - combinação terapêutica para tratamento da doença de alzheimer - Google Patents
combinação terapêutica para tratamento da doença de alzheimerInfo
- Publication number
- BRPI0509881A BRPI0509881A BRPI0509881-5A BRPI0509881A BRPI0509881A BR PI0509881 A BRPI0509881 A BR PI0509881A BR PI0509881 A BRPI0509881 A BR PI0509881A BR PI0509881 A BRPI0509881 A BR PI0509881A
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- alzheimer
- treatment
- therapeutic combination
- treating alzheimer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
COMBINAçãO TERAPêUTICA PARA TRATAMENTO DA DOENçA DE ALZHEIMER. A presente invenção refere-se a composições farmacêuticas úteis para tratar a Doença de Alzheimer. Também são descritos métodos para tratar a Doença de Alzheimer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56214104P | 2004-04-14 | 2004-04-14 | |
PCT/IB2005/000923 WO2005099823A1 (en) | 2004-04-14 | 2005-04-04 | Therapeutic combination for treatment of alzheimers disease |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0509881A true BRPI0509881A (pt) | 2007-10-16 |
Family
ID=34963723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0509881-5A BRPI0509881A (pt) | 2004-04-14 | 2005-04-04 | combinação terapêutica para tratamento da doença de alzheimer |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1737539A1 (pt) |
JP (1) | JP2007532624A (pt) |
KR (1) | KR20060133008A (pt) |
CN (1) | CN1960781A (pt) |
AU (1) | AU2005232447A1 (pt) |
BR (1) | BRPI0509881A (pt) |
CA (1) | CA2562069A1 (pt) |
IL (1) | IL178120A0 (pt) |
MX (1) | MXPA06011969A (pt) |
NO (1) | NO20065196L (pt) |
RU (1) | RU2006136361A (pt) |
TW (1) | TW200533341A (pt) |
WO (1) | WO2005099823A1 (pt) |
ZA (1) | ZA200608239B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI432195B (zh) * | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
US11129801B2 (en) * | 2016-02-11 | 2021-09-28 | Sigmathera Sas | Igmesine for use in the treatment of neurodegenerative diseases |
JP2022537132A (ja) * | 2019-06-14 | 2022-08-24 | ジョシュア オー. アティバ | タンパク性感染症用三重医薬組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
JP2005525391A (ja) * | 2002-04-02 | 2005-08-25 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 認識維持の強化のためのスタチン治療 |
AU2003298514A1 (en) * | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
BR0317747A (pt) * | 2002-12-24 | 2005-11-22 | Neurochem Int Ltd | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave |
WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
EA009668B1 (ru) * | 2003-03-19 | 2008-02-28 | Арес Трейдинг С.А. | Ifn-бета в отдельности или в комбинации с другими лекарственными средствами для лечения болезни альцгеймера и нарушений, связанных с деменцией |
US20050090449A1 (en) * | 2003-05-13 | 2005-04-28 | Boehringer Ingelheim International Gmbh | Novel statine derivatives for the treatment of Alzheimer's disease |
-
2005
- 2005-04-04 AU AU2005232447A patent/AU2005232447A1/en not_active Abandoned
- 2005-04-04 EP EP05718393A patent/EP1737539A1/en not_active Withdrawn
- 2005-04-04 KR KR1020067021174A patent/KR20060133008A/ko not_active Application Discontinuation
- 2005-04-04 MX MXPA06011969A patent/MXPA06011969A/es unknown
- 2005-04-04 CN CNA2005800173902A patent/CN1960781A/zh active Pending
- 2005-04-04 WO PCT/IB2005/000923 patent/WO2005099823A1/en active Application Filing
- 2005-04-04 JP JP2007507862A patent/JP2007532624A/ja not_active Withdrawn
- 2005-04-04 RU RU2006136361/15A patent/RU2006136361A/ru not_active Application Discontinuation
- 2005-04-04 CA CA002562069A patent/CA2562069A1/en not_active Abandoned
- 2005-04-04 BR BRPI0509881-5A patent/BRPI0509881A/pt not_active IP Right Cessation
- 2005-04-13 TW TW094111657A patent/TW200533341A/zh unknown
-
2006
- 2006-09-14 IL IL178120A patent/IL178120A0/en unknown
- 2006-10-03 ZA ZA200608239A patent/ZA200608239B/en unknown
- 2006-11-13 NO NO20065196A patent/NO20065196L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20065196L (no) | 2007-01-03 |
CA2562069A1 (en) | 2005-10-27 |
TW200533341A (en) | 2005-10-16 |
AU2005232447A1 (en) | 2005-10-27 |
JP2007532624A (ja) | 2007-11-15 |
EP1737539A1 (en) | 2007-01-03 |
WO2005099823A1 (en) | 2005-10-27 |
RU2006136361A (ru) | 2008-04-20 |
IL178120A0 (en) | 2006-12-31 |
ZA200608239B (en) | 2008-06-25 |
CN1960781A (zh) | 2007-05-09 |
KR20060133008A (ko) | 2006-12-22 |
MXPA06011969A (es) | 2006-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200901373A1 (ru) | Аминогетероциклические соединения | |
ATE475650T1 (de) | Positive allosterische chinolon-m1- rezeptormodulatoren | |
ECSP055719A (es) | Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos | |
BR0315158A (pt) | Compostos de pirazol para o tratamento de distúrbios neurodegenarativos | |
BR0316350A (pt) | Diaminotriazóis úteis como inibidores de proteìna cinases | |
BRPI0413245A (pt) | compostos heteroarila de 6 membros para o tratamento de distúrbio neurodegenerativos | |
DOP2005000040A (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos | |
EP1841426A4 (en) | TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
ATE530544T1 (de) | Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren | |
BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
EA200801481A1 (ru) | 5-(арилсульфонил)пиразолопиперидины | |
WO2006078576A3 (en) | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease | |
UY30377A1 (es) | Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa | |
EP1817312A4 (en) | MACROCYCLIC AMINIOPYRIDYL BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF MORBUS ALZHEIMER | |
BRPI0509477A (pt) | compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos | |
EA200600971A1 (ru) | Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона | |
BRPI0413709A (pt) | compostos para o tratamento de distúrbios neurodegenerativos | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
ATE409480T1 (de) | Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren | |
CY1110401T1 (el) | Παραγωγα των 1-φαινυλαλκανοκαρβοξυλικων οξεων για την αντιμετωπιση των νευροεκφυλιστικων νοσων | |
ATE371724T1 (de) | Behandlung neurodegenerativer krankheiten | |
PT1778837E (pt) | Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4 | |
BRPI0509881A (pt) | combinação terapêutica para tratamento da doença de alzheimer | |
EA200501865A1 (ru) | Аналоги тиовольфраматов и их применение | |
BRPI0514303A (pt) | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/445 (2006.01), A61P 25/28 (2006.01), A61K |